facebook app symbol  twitter  linkedin  instagram 1

BELLINGHAM, Wash. — The Lummi Public Health Department has submitted an application to participate in a Novavax Covid-19 vaccine trial, a move that is the first step in determining whether the tribe will enroll in the trial. 

Earlier this month, the tribe withdrew from the AstraZeneca Covid-19 vaccine trial, with Lummi Public Health citing communication problems with AstraZeneca representatives following a pause in the study due to adverse reactions experienced by trial participants in the United Kingdom. 

"Native peoples are at higher risk of severe symptoms or death from the coronavirus," said Dakotah Lane, medical director of the Lummi Public Health Department and member of the Lummi Nation, in a statement released by the Lummi Nation. "The AstraZeneca trial was not a good fit, but we continue to believe it's important for our people to have the opportunity to volunteer for a trial as we're at a much higher risk than other populations." 

There will be a three-part process to determining whether the Lummi Nation will participate in the vaccine trial, including review and recommendations by the Northwest Indian College Institutional Review Board (IRB), the Lummi Health and Family Services Commission, and the Lummi Indian Business Council (LIBC). A recommendation will then be forwarded to the Lummi Tribal Health Commission, a six-member group made up of Lummi tribal members, which will review the application and respond to any public concerns. 

If the health commission decides to recommend the vaccine trial, the decision to particpate will then be put to a vote by the LIBC. If approved, the Lummi Public Health Department could begin registering volunteers sometime in November. 

"We know there are concerns from our tribal members and we have taken this to heart," said Lawrence Solomon, chairman of the Lummi Nation, in a statement. "This decision will be made carefully and with community input. Other tribes have experienced such loss from this virus that we want to provide as many options to protect people as possible."

In a statement, Lane emphasized how much is at stake for Native communities when it comes to the impact of Covid-19. 

"If the experts and community approve of proceeding with the Novavax vaccine trial, this will be just one more available option for our tribal members who want to participate." 

More Stories Like This

IHS Deputy Director Asks Tribes to Urge Congress to Make IHS Funding Mandatory
Facebook Study Shows Promise for Native Women Recovering from Opioid Addiction
Native Americans Have Highest Uninsured Rate, New Report Says
Native American World Tennis Champion Brings Racquet Sports to the Rez
FBI MMIP Data Collection Project on Wind River Reservation Falls Short, Advocate Says

The Native News Health Desk is made possible by a generous grant from the National Institute for Health Care Management Foundation as well as sponsorship support from the American Dental Association. This grant funding and sponsorship support have no effect on editorial consideration in Native News Online. 
About The Author
Native News Online Staff
Author: Native News Online StaffEmail: This email address is being protected from spambots. You need JavaScript enabled to view it.
Native News Online is one of the most-read publications covering Indian Country and the news that matters to American Indians, Alaska Natives and other Indigenous people. Reach out to us at [email protected].